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Internally Controlled Real-Time PCR Method for Quantitative
Species-Specific Detection and vapA Genotyping
of Rhodococcus equi†
David Rodrı´guez-La´zaro,1 Deborah A. Lewis,1 Alain A. Ocampo-Sosa,1,3 Ursula Fogarty,3
La´szlo´ Makrai,4 Jesu´s Navas,5 Mariela Scortti,1,2 Marta Herna´ndez,1
and Jose´ A. Va´zquez-Boland1,2*
Bacterial Molecular Pathogenesis Group, Faculty of Medical and Veterinary Sciences, University of Bristol, Langford, United Kingdom1;
Facultad de Veterinaria, Universidad de Leo´n, Leo´n, Spain2; Irish Equine Centre, Johnstown, Naas, Ireland3; Department of
Microbiology and Infectious Diseases, Faculty of Veterinary Science, Budapest, Hungary4; and Departamento de
Biologı´a Molecular, Facultad de Medicina, Universidad de Cantabria, Santander, Spain5
Received 15 November 2005/Accepted 11 April 2006
We developed a novel quantitative real-time PCR (Q-PCR) method for the soil actinomycete Rhodococcus
equi, an important horse pathogen and emerging human pathogen. Species-specific quantification was achieved
by targeting the chromosomal monocopy gene choE, universally conserved in R. equi. The choEQ-PCR included
an internal amplification control (IAC) for identification of false negatives. A second Q-PCR targeted the
virulence plasmid gene vapA, carried by most horse isolates but infrequently found in isolates from other
sources. The choE-IAC and vapA assays were 100% sensitive and specific as determined using 178 R. equi
isolates, 77 nontarget bacteria, and a panel of 60 R. equi isolates with known vapA and vapA-negative
(including vapB) plasmid genotypes. The vapA frequency among isolate types was as follows: horse, 85%;
human, 20%; bovine and pig, 0%; others, 27%. The choE-IAC Q-PCR could detect up to one genome equivalent
using R. equi DNA or 100 bacteria/ml using DNA extracted from artificially contaminated horse bronchoal-
veolar lavage (BAL) fluid. Quantification was linear over a 6-log dynamic range down to 10 target molecules
(or 1,000 CFU/ml BAL fluid) with PCR efficiency E of >0.94. The vapA assay had similar performance but
appeared unsuitable for accurate (vapA) R. equi quantification due to variability in target gene or plasmid
copy number (1 to 9). The dual-reaction Q-PCR system here reported offers a useful tool to both medical and
veterinary diagnostic laboratories for the quantitative detection of R. equi and (optional) vapA “horse-
pathogenic” genotype determination.
Rhodococcus equi is a soil-dwelling actinomycete of the my-
colata group that causes pyogranulomatous infections in the
lungs and other different body locations in a variety of animal
hosts. This facultative intracellular parasite is well known in
veterinary medicine as the causal agent of foal pneumonia, a
severe purulent bronchopneumonic infection with high case-
fatality rates. The disease is recognized in many countries as
the leading cause of mortality in foals and is a cause of serious
concern to the equine industry as it can become endemic in
stud farms and there is no effective vaccine for its prevention
(9, 23). In recent years R. equi has emerged as an opportunistic
human pathogen, especially in individuals infected with human
immunodeficiency virus. In the human host the infection pre-
sents usually as tuberculosis-like cavitary pneumonia or bacte-
remia (2, 36). R. equi is also being increasingly reported in
other animal species, mainly associated with extrapulmonary,
purulent, caseating infections (5, 33). In cattle the organism is
typically isolated from chronic retropharyngeal, bronchial, or
mediastinal pyogranulomatous lymphadenitis (6) and in pigs
from submaxillary lymph nodes (18).
Horse isolates of R. equi typically harbor an 85- to 90-kb
virulence plasmid, of which an example has been fully se-
quenced (11, 32). This plasmid encodes virulence-associated
protein A or VapA, a 17.4-kDa surface lipoprotein presumed
to be involved in pathogenesis but whose role in the infectious
process remains unknown (10, 14). VapA is encoded by the
vapA gene, which is present in a plasmidic, 27.5-kb pathoge-
nicity island together with six other vapA homologues (32). In
nonhorse R. equi isolates, including human isolates, the VapA
protein/vapA gene is much less frequently found than a variant
protein/allele designated VapB/vapB. The VapB antigen is
structurally and immunologically closely related to VapA but is
larger (18.2 to 20 kDa as detected by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis immunoblotting) and is en-
coded by plasmids of various sizes (79 to 100 kb), not yet
characterized genetically. The vapB plasmids are not found in
equine isolates, suggesting that vapB strains are not patho-
genic for the horse (22, 31, 34). Except for soil isolates from
horse breeding farms, in which vapA-type plasmids are com-
mon, environmental isolates of R. equi do not usually carry
plasmids, or if they do, these are smaller in size and most often
vapA and vapB negative (31).
Laboratory diagnosis of rhodoccocal infections currently re-
lies on classical bacteriological methods involving the isolation
* Corresponding author. Mailing address: Veterinary Molecular Mi-
crobiology Section, Faculty of Medical and Veterinary Sciences, Uni-
versity of Bristol, Langford BS40 5DU, United Kingdom. Phone: 44
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of the organism from clinical samples or postmortem material
(23). However, these culture-based procedures are lengthy and
sometimes lack adequate sensitivity due either to prior antibi-
otic treatments or, in the case of respiratory specimens (typi-
cally bronchoalveolar lavage [BAL] aspirate or sputum), to the
presence of multiple bacterial contaminants (28). An added
problem is the difficulties posed by the identification due to the
micro- and macroscopic morphological variability exhibited by
these bacteria and the lack of accuracy of biochemical tests for
R. equi species determination (8, 15, 29, 36). There is therefore
considerable interest in developing new, simpler tests for the
rapid and reliable detection and identification of R. equi for
use in both veterinary and medical clinical microbiology labo-
ratories.
Several molecular methods for R. equi have been described
based on amplification of DNA sequences by conventional
PCR (1, 3, 12, 15, 22, 28, 30). Although comparatively faster
than culture-based methods, conventional PCR, however, pro-
vides only qualitative results and requires post-PCR proce-
dures. The “open” post-PCR processing of massive amounts of
amplicon increases the risk of false-positive results due to
sample cross-contamination. This risk is minimized in the real-
time PCR technique as the reaction and fluorescent probe-
based amplicon detection are brought about simultaneously in
a closed tube. Real-time monitoring of the amplification curve
via fluorescence emission permits also a much more sensitive
detection of positive reactions and at the same time, impor-
tantly, an accurate quantification of the target DNA present in
the sample (35). However, to date only one quantitative real-
time PCR (Q-PCR) assay has been reported for R. equi (13).
This assay targets the vapA gene and therefore detects only
strains carrying vapA plasmids, which as mentioned above are
rarely found in human and most other nonhorse R. equi iso-
lates, thus limiting its applicability to the field of equine med-
icine. Moreover, the quantification accuracy of this assay can
be compromised by strain-to-strain differences in plasmid copy
number or plasmid DNA extraction efficiency.
We recently identified the R. equi cholesterol oxidase gene
choE and demonstrated that this chromosomal locus is univer-
sally conserved in these bacteria (21) and is a suitable target for
their specific and sensitive detection by conventional PCR
(15). Here we report the design and development of a novel
dual-reaction Q-PCR method that allows both the species-
specific quantification of R. equi and determination of its
“horse-associated” subtype via detection of choE and vapA
sequences, respectively. The method includes an internal am-
plification control (IAC) for monitoring the occurrence of
false-negative results due to PCR failure or inhibition.
MATERIALS AND METHODS
Bacterial strains, culture media, and growth conditions. A total of 255 bac-
terial strains were used in this study: 197 were Rhodococcus spp. (178 R. equi and
19 non-R. equi isolates) and 58 belonged to different actinomycete genera,
including cholesterol oxidase-producing species. The R. equi strains included
horse (n  81), human (n  35), pig (n  30), bovine (n  8), soil (n  13), and
ancillary (n  11, from sheep, goat, dog, cat, pheasant, primate, iguana, and
unknown origin) isolates from 14 countries (Argentina, Australia, Brazil, Can-
ada, China, Dominican Republic, Germany, France, Hungary, Ireland, Japan,
Slovenia, Spain, and the United Kingdom). All were confirmed as R. equi by
analysis of colony morphology, API Coryne biochemical profiling, synergistic
hemolysis (CAMP-like) test with Listeria ivanovii (21), and our previously de-
scribed conventional choE-PCR test (15). R. equi isolate 103S from J. Prescott
(University of Guelph, Canada), deposited as PAM 1126 in our collection, was
used as the reference strain. This strain was originally isolated from a case of foal
pneumonia and is currently being used for the determination of the complete
genome sequence of R. equi by the International R. equi Genome Consortium
(www.sanger.ac.uk/Projects/R_equi). A detailed list of R. equi isolates is available
in the supplemental material as Table S1. The non-R. equi isolates are listed in
Table S2 in the supplemental material. Bacteria were maintained at 80°C in a
medium containing 2% tryptone, 4% skimmed milk, and 16% glycerol. Rhodo-
coccus spp. were grown at 30°C in brain heart infusion (BHI) and non-Rhodo-
coccus isolates at 37°C in YME medium (0.4% yeast extract, 1% malt extract,
0.4% glucose), supplemented with 1.5% agar for plate cultures. All media were
purchased from Oxoid (Hampshire, United Kingdom), except BHI (from Difco-
BD, Detroit, MI).
DNA isolation and quantification. Bacterial genomic DNA was isolated from
overnight cultures on solid medium using a cetyltrimethylammonium bromide
(CTAB)-based protocol. Bacterial colonies from half a petri dish were collected
with a loop, suspended in 1 ml phosphate-buffered saline, pelleted at 4,000  g
for 10 min, and incubated for 1 h at 37°C after resuspension in 567 l Tris-EDTA
buffer and 3 l 100-mg/ml (30,000 units) lysozyme (Sigma) solution. Subse-
quently, 30 l 10% sodium dodecyl sulfate and 3 l 20-mg/ml (1.8 units) pro-
teinase K (Sigma) was added and the mixture was incubated again for 1 h at
37°C. Then, 170 l 5 M NaCl, 80 l CTAB-NaCl solution (10% CTAB in 0.7 M
NaCl), and 5 l 100-mg/ml (50 Kunitz units) RNase A (Sigma) were added
followed by a 30-min incubation at 65°C. After cooling to room temperature, the
mixture was extracted with phenol-chloroform and chloroform-isoamyl alcohol
followed by DNA precipitation with isopropanol and washing with 70% ethanol
(27). DNA was resuspended in 100 l 10 mM Tris-HCl, pH 8.0, and its amount
and quality were determined spectrophotometrically by calculating the ratio of
optical density at 260 nm to that at 280 nm and visually by agarose gel electro-
phoresis.
Oligonucleotides. The oligonucleotide primers and TaqMan probes used in
this study were designed using Primer Express 2.0 software (Applied Biosystems,
Foster City, CA) and purchased from Metabion AG (Martinsried, Germany).
They are listed in Table 1. The IAC probe was labeled with HEX (6-carboxy-
2,4,4,5,7,7-hexachlorofluorescein) and the choE probe with 6-carboxyfluores-
cein (FAM).
IAC construction. The IAC consisted of a 100-bp chimerical DNA containing
a portion of the listeriolysin (hly) gene from Listeria monocytogenes (GenBank
accession no. M24199), which we previously validated as a Q-PCR probe target
(24), flanked by the R. equi-specific choE gene sequences targeted by reqF and
reqR primers (Table 1). This chimeric DNA molecule was generated by two
rounds of PCR as previously described (26). The first PCR used 1 ng L. mono-
cytogenes DNA template and primers riacF and riacR (Table 1), which contained
the corresponding hly target sequences plus a 5 tail with the reqF or reqR primer
sequence. The second PCR used the purified first-round PCR product (diluted
1:1,000) as a template and the reqF and reqR primers. PCR conditions were as
previously described (26). The IAC PCR product was purified using the QIAquick
gel extraction kit (QIAGEN, Hilden, Germany), quantified, and diluted to the
appropriate concentration in 10 mM Tris-HCl, pH 8.0, in the presence of 500
ng/ml of acetylated bovine serum albumin as a blocking agent to minimize
binding of the negatively charged IAC DNA to the plastic microtubes. With the
exception of its target sequence in the L. monocytogenes hly gene (nucleotide
positions 114 to 177), the IAC did not display significant similarity to any DNA
sequence deposited in public databases, as determined by BLAST-N searches
(National Center for Biotechnology Information, Bethesda, Md.; http://www
.ncbi.nlm.nih.gov). The IAC amplicon, 100 bp in size, was longer than the 68-bp
choE-specific amplicon, facilitating the differentiation of the two PCR products
by gel electrophoresis.
Q-PCR. The assays were performed essentially as described previously (24) in
20-l reaction volumes containing 1 PCR buffer II; 6 mM MgCl2; 200 M
dATP, dCTP, and dGTP; 400 M dUTP; 300 nM specific primers; 150 nM probe
(for the duplex choE-IAC system, 100 nM of IAC probe was added); 1 unit of
AmpliTaq Gold DNA polymerase (Applied Biosystems-Roche Molecular Sys-
tems Inc., Branchburg, N.J.); 0.2 units of AmpErase uracil N-glycosylase; and 5
l of the target DNA solution. Reactions were run on an iCycler IQ platform
(Bio-Rad Laboratories Inc., Hercules, CA) with the following program: 2 min at
50°C, 10 min at 95°C, and 50 cycles of 15 s at 95°C and 1 min at 60°C. Q-PCR
results were analyzed using the Optical System Software v3.0a (Bio-Rad Labo-
ratories Inc., Hercules, CA). Quantification was obtained by interpolation in a
standard regression curve of cycle threshold (CT) values generated from samples
of known DNA concentrations. One molecule of R. equi DNA, or genome
equivalent, corresponds to approximately 5.5 fg of DNA considering a genome
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size of 5.2 Mb as determined for PAM 1126, according to the following equation:
DNA amount in fg  bp  660 Da/bp  1.6  1027 kg/Da  1  1018 fg/kg
(25). Q-PCRs with CT values of 50 were considered negative. The 95% con-
fidence interval was calculated for every serial dilution according to a binomial
distribution (with the statistical software SPSS 12.0S for Windows v8.0 [SPSS
Inc., Chicago, Ill.]) (25, 26). Unless otherwise stated, all reactions were per-
formed in triplicate.
Quantitative detection of R. equi in BAL fluid. An overnight culture in BHI of
R. equi PAM 1126 was centrifuged for 3 min at 3,000 g, the bacterial pellet was
resuspended in sterile phosphate-buffered saline, and the suspension was serially
10-fold diluted in BAL fluid obtained from a healthy adult horse with the use of
0.9% NaCl intravenous infusion solution (Baxter Healthcare Corp.) as vehicle.
The concentration of R. equi in the BAL fluid dilutions was determined by
standard plate counting. DNA was extracted from R. equi-contaminated BAL
dilutions as follows: 1-ml samples were transferred to clean 1.5-ml microtubes
and centrifuged for 5 min at 10,000  g at 4°C; the pellets were resuspended in
100 l Instagene Matrix suspension (Bio-Rad Laboratories, Hercules, CA) by
vortexing, and the suspensions were incubated at 56°C for 20 min; after 10 s of
vigorous vortexing, these were incubated at 100°C for 8 min and then placed on
ice and centrifuged for 5 min at 14,000  g at 4°C; finally, 50 l of the super-
natants was transferred to a fresh microtube and stored at20°C until use. Each
PCR used 5 l of DNA preparation.
RESULTS
Design and optimization of choE- and vapA-specific Q-PCR
assays. To specifically identify R. equi, we used the conserved
choE gene (21) as a target. A previously developed conven-
tional PCR assay based on detection of choE sequences was
100% specific and sensitive for R. equi taking as a positive
result the expected 959-bp amplicon (15). Using this PCR
assay, smaller products are occasionally observed with other
rhodococcal species (reference 12 and our unpublished obser-
vations). To minimize the risk of unspecific reactions, we iden-
tified a new choE target region suitable for Q-PCR primers
and probe design by careful analysis of all cholesterol oxidase
gene sequences deposited in public databases using the
CLUSTALW multiple-alignment tool (European Bioinfor-
matics Institute, EMBL; www.ebi.ac.uk). The new choE prim-
ers, reqF and reqR (Table 1), amplify a 100% specific, con-
served 68-bp DNA fragment corresponding to positions 938 to
1005 of the coding sequence deposited in GenBank under
accession no. AJ242746 (21).
Gene regions suitable for vapA-specific Q-PCR oligonucle-
otides were selected by visual inspection of CLUSTALW mul-
tiple alignments of all known sequences of the vap multigene
family. These include, in addition to vapA, six other vap genes
(vapC to -H, identified in vapA virulence plasmids from
strains ATCC 33701 and 103) (32) and vapB identified in
plasmids from “nonequine” R. equi isolates (22). Primer pair
RvapA114F-RvapA188R amplifies a vapA-specific, conserved
75-bp DNA fragment corresponding to positions 114 to 188 of
the gene sequence deposited in GenBank with accession no.
NC002576 (32).
The BLAST-N tool v.2.2.12 was used (with default settings
and low-complexity filter off) to confirm in silico that none of
the selected oligonucleotides recognized any registered DNA
sequence other than the target sequence. Primers, TaqMan
probes, and MgCl2 concentrations were optimized for Q-PCR
assays by using 1 ng of template DNA from R. equi strain PAM
1126. The minimum primer and probe concentrations that
gave the lowest CT value and the highest fluorescence intensity
were retained as the standard optimal conditions (see Materi-
als and Methods).
Optimization of duplex choE-IAC Q-PCR assay. The opti-
mal IAC probe concentration (i.e., the minimum concentration
not resulting in an increase of CT) (26), 100 nM, was experi-
mentally determined by performing Q-PCRs in the presence of
TABLE 1. Oligonucleotides used in this study
Target Oligonucleotidename Application Sequence
Tm
a
(°C)
G-C
(%) Reference(s)
choE reqF Q-PCR forward primer 5-CGA CAA GCG CTC GAT GTG-3 59 61 This study
reqR Q-PCR reverse primer 5-TGC CGA AGC CCA TGA AGT-3 59 56 This study
reqP TaqMan probe 5-FAM-TGG CCG ACA AGA CCG ATC AGC
C-TAMRAb-3
69 64 This study
COX-F PCR forward primer 5-GTC AAC AAC ATC GAC CAG GCG-3 62.3 57.1 15
COX-R PCR reverse primer 5-CGA GCC GTC CAC GAC GTA CAG-3 64.7 66.7 15
vapA RvapA114F Q-PCR forward primer 5-CAG CAG TGC GAT TCT CAA TAG TG-3 59 48 This study
RvapA188R Q-PCR reverse primer 5-GAA GTC GTC GAG CTG TCA TAG CT-3 59 52 This study
RvapA140P TaqMan probe 5-FAM-CAG AAC CGA CAA TGC CAC TGC
CTG-TAMRA-3
69 58 This study
IP1 PCR forward primer 5-AC TCT TCA CAA GAC GGT-3 46 50 22, 30
IP2 PCR reverse primer 5-TAG GCG TTG TGC CAG CTA-3 55.1 55.6 22, 30
vapB H1 PCR forward primer 5-TGA TGA AGG CTC TTC ATA A-3 47.6 36.8 22
H2 PCR reverse primer 5-TTA TGC AAC CTC CCA GTT G-3 53.2 47.4 22
IAC IACP TaqMan probe 5-HEX-CGC CTG CAA GTC CTA AGA CGC
CA-TAMRA-3
68 61 24
hly riacF Forward primer IAC
construction
5-CGA CAA GCG CTC GAT GTG CAT GGC
ACC ACC-3
81 63 This study
riacR Reverse primer IAC
construction
5-CGA CAA GCG CTC GAT GTG ATC CGC
GTG TTT-3
78 57 This study
a Theoretical melting temperature.
b TAMRA, 6-carboxytetramethylrhodamine.
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1,000 IAC molecules, no R. equi DNA, 150 nM FAM-labeled
choE probe, and increasing amounts (from 25 to 250 nM) of
HEX-labeled IAC probe. Since an excess of IAC may inhibit
the target-specific reaction, Q-PCRs were also carried out in
the presence of various IAC amounts (10,000, 1,000, 100, and
10 molecules per reaction) and a fixed amount (30 genome
equivalents) of R. equi PAM 1126 DNA. The maximum IAC
amount with no inhibitory effect on the choE-specific FAM
signal was 100 copies.
Specificity and sensitivity of the choE-IAC Q-PCR. The ca-
pacity of the choE Q-PCR assay to discriminate between target
and nontarget bacteria was assessed using 1 ng of genomic
DNA from 178 R. equi strains from a variety of sources (in-
cluding clinical isolates from different animal species and en-
vironmental isolates), 19 non-R. equi rhodococcal species
strains, and 58 strains from 18 different non-Rhodococcus
actinomycete genera. The choE Q-PCR assay was 100% sen-
sitive and 100% specific as all 178 R. equi strains tested gave a
positive choE signal whereas none of the 77 nontarget bacteria
did (detailed results in Table S1 in the supplemental material).
Rhodococcus fascians, reported by others (12) to give an un-
specific (smaller) amplicon by conventional PCR using our
previously described primers (15), did not give any significant
signal in the choE Q-PCR assay. All the reactions generated a
positive IAC (HEX) signal, ruling out that the absence of choE
(FAM) signal observed in non-R. equi isolates was due to
failure of the PCR. All the nonactinomycete bacteria that we
have tested to date, including a variety of common gram neg-
atives and gram positives, have yielded negative results in the
choE Q-PCR assay (not shown).
Specificity and sensitivity of the vapA Q-PCR. As with the
choE PCR, none of the 77 nontarget bacteria (non-Rhodococ-
cus strains and non-R. equi rhodococci) gave a positive ampli-
fication signal with the vapA Q-PCR. However, this assay de-
tected the target sequence in only 48% of R. equi isolates (85
out of 178), as expected from the varied composition of the
strain panel tested, which contained only a proportion of
horse-derived bacteria (see above and Table S1 in the supple-
mental material). The distribution of vapA isolates per ani-
mal species is shown in Fig. 1.
The discrimination capacity of the vapA Q-PCR assay was
assessed on a selection of 60 R. equi strains using as reference
method a previously described dual-reaction conventional
PCR system that differentiates vapA isolates from vapB-neg-
ative or vapA- and vapB-negative isolates using two pairs of
primers (22). Prior to applying this method, we confirmed its
100% efficacy on a representative sample of R. equi strains with
known vapA/B genotypes (17, 18). As shown in Table 2, there
was a perfect concordance between the results obtained by the
two techniques. As all the strains tested positive with the choE-
IAC system, these results indicated that our vapA Q-PCR assay
is 100% specific and 100% sensitive.
Detection and quantification limits of the choE-IAC and
vapA Q-PCR assays. The detection and quantification limits of
the developed PCR assays were determined by using R. equi
PAM 1126 genomic DNA. Amplification reactions were per-
formed with a range of DNA concentrations equivalent to
approximately 1  106, 1  105, 1  104, 1  103, 1  102, 10,
and 1 target molecule. Figure S1 in the supplemental material
illustrates typical amplification profiles and the regression
curves obtained with each Q-PCR assay; Table 3 shows the
mean CT values for a total of nine replicates in three indepen-
dent experiments. The two Q-PCR assays yielded similar re-
sults in terms of absolute detection values. Positive amplifica-
tion in all nine replicates of each DNA dilution was achieved
when 10 or more target molecules were present, and as few as
one target molecule could be detected with 67 to 78% proba-
bility for choE- and vapA-based Q-PCR assays, respectively
(Table 3). The slopes of the linear regression curves calculated
over a 6-log range were similar to the theoretical optimum of
3.32 (26) (choE, 3.337; choE-IAC duplex reaction, 3.335;
vapA, 3.379) and showed that the amplifications were very
efficient (E  0.994 	 0.001, 0.995 	 0.002, and 0.977 	 0.002
for choE-, choE-IAC-, and vapA-based Q-PCR assays, respec-
tively). Moreover, R2 values were above the optimal 0.995
(0.998 for choE and choE-IAC reactions, 0.999 for vapA reac-
tion), indicating that the Q-PCRs that we developed are ap-
propriately linear. The confidence intervals based on the stan-
dard deviations of CT values did not overlap each other down
to 10 target molecules, indicating that reliable quantification
was possible above this limit.
Quantitative detection of R. equi in BAL fluid. We assessed
the applicability of the choE-IAC Q-PCR for the quantitative
detection of R. equi bacteria in artificially contaminated BAL
fluid. Taking into consideration that 100 l of DNA was ob-
tained from the processing of 1 ml of BAL fluid, and that 5 l
of DNA preparation was used for the PCR, our choE-IAC
assay consistently detected down to approximately 100 R. equi
cells/ml or 5 genomic units per reaction (Table 4). Quantitative
amplification parameters were optimal, with linearity (R2)
above 0.99 down to 1  103 R. equi CFU/ml and overall PCR
efficiency of 0.94. Relative accuracy values (24, 27) ranged
between 88.95% and 113.53%, indicating a high degree of
correspondence between the quantitative results obtained
by the reference method (number of R. equi CFU/ml as
FIG. 1. Distribution of the vapA allele according to isolate origin.
The number of isolates within each category is indicated above the
bars; within the bars are the percentages of vapA (gray section) and
vapA-negative (empty section) isolates. “Other” includes sheep, goat,
dog, cat, pheasant, primate, iguana, and unknown origin. Most soil
isolates are from equine-related environments, explaining the rela-
tively high percentage of vapA isolates (31).
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determined by plate counting) and the results obtained by
the choE Q-PCR method (Table 4).
DISCUSSION
We describe here a Q-PCR method that permits the sensi-
tive and specific, accurate quantitative detection of the patho-
genic actinomycete R. equi. This is achieved by targeting se-
quences from the chromosomal choE gene, previously
identified in our laboratory and shown to provide a useful
marker for the molecular detection and identification of R.
equi (15, 21). A previous Q-PCR assay for R. equi, recently
reported by others (14), targets the plasmidic gene vapA and
thus detects only R. equi bacteria carrying this allelic variant.
vapA strains are associated with infections in the horse and
hence are predominantly found in equine-associated speci-
mens. However, R. equi can be isolated from a variety of other
animal species in which, with few exceptions, vapA strains are
rarely found (17, 19, 22, 34) (Fig. 1). Indeed, our data show
that only a small proportion (20%) of human clinical isolates
are vapA, consistent with previously reported figures on the
prevalence of VapA/vapA R. equi bacteria in human speci-
mens (12, 22, 34). The vapA plasmid genotype appears to be
particularly rare among bovine and pig isolates, as shown by
our data (0% positives; Fig. 1) and other studies (6, 17). Over-
all, more than 50% of the isolates tested in this study were
vapA negative (Fig. 1), clearly showing that a vapA-only-based
detection assay misses a very significant proportion of common
R. equi strains. Importantly, 15% of the horse clinical isolates
included in our study were vapA negative (Fig. 1), question-
ing the value of vapA as a sensitive molecular diagnostic
marker for R. equi even if its application is restricted to
equine specimens.
Besides being universally highly conserved in R. equi, the
choE gene offers also the advantage that it is present on the
chromosome in monocopy (21), thus permitting an accurate
quantification of the genomic units present in a sample. In
contrast, the detection (and quantification in terms of genome
equivalents) of a plasmidic gene, as is vapA, relies on the
efficiency of plasmid DNA extraction and, critically, also on the
number of copies of the plasmid carried by each individual
strain. From the CT values obtained for choE (control monocopy
gene) and vapA we have estimated that 39% of the isolates
contained two or more plasmid copies per genome (Table 5),
indicating that Q-PCR data based on vapA would overestimate
on a significant number of occasions the R. equi bacterial load
present in the sample by at least a factor of two.
Although vapA is clearly unsuitable as a target for the spe-
cies-specific quantitative detection of R. equi by Q-PCR, it is
indisputable that this gene has diagnostic value as a predictor
of horse pathogenicity (31). Moreover, horse isolates are quan-
titatively the most significant component of R. equi epidemiol-
ogy. Indeed, this fully justifies the incorporation of vapA de-
tection capabilities in any diagnostic method targeting R. equi.
Bearing this in mind, we designed our Q-PCR method for R.
equi as a dual-reaction system with independent assays for
choE and vapA, the former as an entry-level, primary test
aiming at the quantitative detection of R. equi species, and the
latter as a complementary, optional test for vapA genotype
determination. This modular design provides full flexibility as
TABLE 2. Specificity and sensitivity of vapA Q-PCRa
Strain Origin
Conventional
PCR resultb
Q-PCR
result
for vapA
Concordancec
vapA vapB
PAM 1126 Horse    
PAM 1286 Iguana    
PAM 1335 Horse    
PAM 1340 Horse    
PAM 1346 Horse    
PAM 1348 Soil    
PAM 1350 Soil    
PAM 1351 Soil    
PAM 1358 Horse    
PAM 1365 Horse    
PAM 1367 Horse    
PAM 1371 Horse    
PAM 1374 Horse    
PAM 1376 Human    
PAM 1387 Unknown    
PAM 1404 Horse    
PAM 1406 Human    
PAM 1408 Horse    
PAM 1410 Horse    
PAM 1413 Human    
PAM 1414 Human    
PAM 1415 Human    
PAM 1416 Horse    
PAM 1418 Horse    
PAM 1422 Horse    
PAM 1424 Horse    
PAM 1425 Horse    
PAM 1427 Horse    
PAM 1430 Horse    
PAM 1431 Horse    
PAM 1436 Soil    
PAM 1437 Horse    
PAM 1441 Soil    
PAM 1447 Pig    
PAM 1448 Human    
PAM 1453 Horse    
PAM 1463 Human    
PAM 1467 Pig    
PAM 1468 Pig    
PAM 1469 Pig    
PAM 1473 Pig    
PAM 1474 Pig    
PAM 1475 Pig    
PAM 1479 Pig    
PAM 1480 Pig    
PAM 1483 Pig    
PAM 1485 Pig    
PAM 1487 Pig    
PAM 1488 Pig    
PAM 1493 Pig    
PAM 1495 Pig    
PAM 1499 Pig    
PAM 1500 Pig    
PAM 1504 Pig    
PAM 1518 Pig    
PAM 1533 Pig    
PAM 1547 Pig    
PAM 1549 Pig    
PAM 1550 Pig    
PAM 1563 Bovine    
a Note that vapA and vapB scores are mutually exclusive, indicating that
vapB is most likely an allelic variant of vapA. , positive; , negative.
b Reference method (primers, PCR setup, and conditions as described in
references 22 and 30).
c Concordance between results of vapA conventional PCR and our vapA Q-PCR.
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the vapA Q-PCR assay will not always be needed, in particular
in medical (human) microbiology laboratories, due to its spe-
cific relevance for the horse. It also helps avoid possible prob-
lems of loss of analytical performance, as is sometimes seen in
multiplex PCR assays (7, 16). This is important as the primary
choE Q-PCR test includes an IAC, thus being already de facto
a duplex-format assay.
A major limitation to the application of Q-PCR-based tests
in diagnostic laboratories is the relatively common occurrence
of false-negative results due to the presence of PCR inhibitors
in the sample. To tackle this problem, we included an IAC in
our choE Q-PCR assay. An IAC consists of a nontarget DNA
fragment that is coamplified with the target sequence, prefer-
ably with the same primers used for the test reaction (4, 26). To
achieve this, we constructed the IAC by fusing the forward and
reverse choE target sequences to both ends of an unrelated
DNA fragment to which a second fluorescent probe (the IAC
probe) hybridized. The use of two differently labeled fluores-
cent probes in the same reaction permitted the simultaneous
detection/quantification of the target DNA and assessment of
PCR efficiency. The inclusion of an IAC did not have any
significant impact on the performance of the choE Q-PCR
assay (Table 3).
A critical aspect in the design of molecular diagnostic meth-
ods for microbial pathogens is achieving low detection and
quantification limits. This goal is of particular interest in the
case of R. equi. Indeed, rhodococcal foal pneumonia initially
follows an insidious course (9, 23), and it has been suggested
that accurate detection (and quantification) of low levels of R.
equi in respiratory specimens during the “silent” phase of in-
fection, before the development of gross lesions in the lungs
and the manifestation of clinical symptoms, could be of diag-
nostic value (13, 20). On purified DNA, our choE Q-PCR assay
could detect approximately one target genome equivalent in at
least 67% of the replicates and 10 genome equivalents in all
cases. Accurate quantification, with excellent linearity (R2 
0.998) and efficiency (E  0.994 without IAC and 0.995 with
IAC), was possible down to 10 R. equi genome equivalents
TABLE 3. Determination of the detection and quantification limits of R. equi choE, choE-IAC, and vapA Q-PCR assaysa
Approx no. of
genome eq/reaction
Confidence interval limitb Signal ratio for assay c: CT for assayd:
Lower Upper choE choE-IAC vapA choE choE-IAC vapA
1  106 997,600 1,003,300 9/9 9/9 9/9 19.83	 0.02 19.90 	 0.04 18.80 	 0.02
1  105 99,643 100,358 9/9 9/9 9/9 23.32	 0.05 23.40 	 0.06 22.25 	 0.06
1  104 9,887 10,113 9/9 9/9 9/9 26.05	 0.02 26.01 	 0.03 25.60 	 0.03
1  103 964 1,036 9/9 9/9 9/9 29.50	 0.02 29.60 	 0.04 29.00 	 0.03
1  102 89 111 9/9 9/9 9/9 32.88 	 0.03 32.95 	 0.05 32.20 	 0.04
1  101 7 14 9/9 9/9 9/9 36.77 	 0.15 36.80 	 0.14 35.80 	 0.12
1 0 2 6/9 6/9 7/9 38.38 	 0.41 38.70 	 0.34 38.20 	 0.29
a Nontemplate controls were negative in the three Q-PCR assays (CT values of 50 in all the replicates).
b Calculated for the expected number of template molecules at each dilution at 95% confidence level.
c Number of positive results out of nine reactions.
d Cycle number at which fluorescence intensity equals a fixed threshold. Mean values 	 standard errors of the means were calculated with a prefixed threshold of
200. Differences in CT values were statistically significant with P 
 0.05.
TABLE 4. Quantitative detection of R. equi bacteria in BAL fluida
Approx
R. equi
CFU/ml
Approx no. of
R. equi genome
eq/reactionb
Signal
ratioc CT
d Relative
accuracy e
1  107 5  105 9/9 20.67 	 0.10 100.05
1  106 5  104 9/9 24.10 	 0.10 103.59
1  105 5  103 9/9 27.82 	 0.04 88.95
1  104 5  102 9/9 30.93 	 0.13 113.53
1  103 5  101 9/9 34.68 	 0.20 95.57
1  102 5  100 9/9 37.90 	 0.21 NAf
1  101 5  101 0/9 50 NA
1 5  102 0/9 50 NA
0g 0 0/9 50 NA
a Results from three independent experiments with three replicates each.
Overall efficiency E is 0.94, and linearity R2 is 0.99.
b Estimated number of R. equi genome equivalents in each PCR run assuming
100% DNA extraction efficiency (each reaction mixture contained 5 l of a DNA
preparation of 100 l extracted from 1 ml BAL fluid).
c Number of positive results out of nine reactions.
d As defined in Table 3, footnote d.
e Degree of correspondence between the quantitative results obtained by stan-
dard plate counting (R. equi CFU/ml) and the results obtained by the choE
Q-PCR method (27, 29).
f NA, not applicable.
g Noncontaminated BAL fluid.
TABLE 5. Numbers of copies of the vapA gene in R. equi isolatesa
Avg no. of copies of vapA for value type
% of
isolatesExptl continuous
range
Theoretical
discrete
0.57b–1.49 1 61.2
1.50–2.49 2 25.9
2.50–3.49 3 5.9
3.50–4.49 4 0
4.50–5.49 5 1.2
5.50–6.49 6 1.2
6.50–7.49 7 2.4
7.50–8.49 8 0
8.50–9.49 9 1.2
Total 100
a Estimated from Q-PCR results for choE and vapA in vapA isolates (at least
three replicates per reaction per isolate) using 1 ng of DNA and the following
formula: number of vapA copies  2CT, where CT  CTvapA  CTchoE,
assuming 100% plasmid DNA extraction efficiency relative to chromosomal
DNA. This calculation is possible because the PCR efficiencies for both targets,
0.977 and 0.995, were close to the optimal value E  1, meaning that duplication
of each amplicon occurs in each cycle across a wide linear range. The coefficient
of variance was 7% and 11% for choE and vapA Q-PCR systems, respectively.
b Minimum value obtained (see Table S1 in the supplemental material).
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per reaction. A similar performance was achieved when the
technique was applied to the enumeration of bacterial cells in
BAL fluid, a specimen commonly used in the clinical diagnosis
of R. equi pneumonia (9, 28). Here, due to the DNA extraction
protocol used, which involved processing of 1-ml BAL fluid
samples, and the inclusion per reaction of a fraction of DNA
extract (5 out of 100 l), the practical detection limit for R.
equi bacteria was 100 CFU/ml (or 5 genome equivalents per
reaction). It should be possible to lower this detection limit by
refining the sample processing so that DNA is extracted from
larger specimen amounts and recovered in smaller volumes.
Moreover, accurate determination of horse-pathogenic (i.e.,
vapA) R. equi numbers in environmental samples or in fecal
or nasal specimens could also provide a predictive tool to
assess the risk of R. equi clinical infection in stud farms where
the organism is endemic. The optimal performance parameters
of our vapA Q-PCR (R2  0.999, E  0.977) indicate that this
assay is suitable for this purpose.
In conclusion, the dual-reaction Q-PCR method that we
have developed for the rapid (results in less than 2 h), species-
specific quantitative monitoring and determination of the
vapA (equine) subtype of R. equi provides a diagnostic tool
potentially very useful in both medical and veterinary diagnos-
tic laboratories.
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